- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
ABL Bio Inc (298380)
Assess today's live ABL Bio Inc (298380) share price, performance and insights using our live KOSDAQ: 298380 stock exchange data.
Analyse the historical data and ABL Bio Inc share price performance charts on this page. Our technical summary section provides analysis on ABL Bio share price buy/sell indicators using real-time data (or discuss the ABL Bio (298380) stock price today with other investors in the ABL Bio KQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current KQ 298380 share price (ISIN: KR7298380007) to enhance your trading decisions with our free investment tools and resources.
What Is the ABL Bio Inc Share Price Today?
The ABL Bio share price today is 185,800.
What Is the Stock Symbol for ABL Bio Inc
The stock symbol (or 'ticker') for ABL Bio Inc is "298380."
What Stock Exchange Does ABL Bio Inc Trade On?
ABL Bio Inc is listed and trades on the KOSDAQ stock exchange.
Is ABL Bio Inc a Good Stock to Buy?
Determining whether ABL Bio Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and ABL Bio Inc share price performance charts on this page. Our technical summary section provides analysis on ABL Bio share price buy/sell indicators using real-time data (or discuss the ABL Bio (298380) stock price today with other investors in the ABL Bio KQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current KQ 298380 share price (ISIN: KR7298380007) to enhance your trading decisions with our free investment tools and resources.
What Is the ABL Bio Inc Share Price Today?
The ABL Bio share price today is 185,800.
What Is the Stock Symbol for ABL Bio Inc
The stock symbol (or 'ticker') for ABL Bio Inc is "298380."
What Stock Exchange Does ABL Bio Inc Trade On?
ABL Bio Inc is listed and trades on the KOSDAQ stock exchange.
Is ABL Bio Inc a Good Stock to Buy?
Determining whether ABL Bio Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
KOSDAQ
Currency in KRW
185,800
-3,400(-1.80%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
185,200
193,000
52 wk Range
31,300
257,500
298380 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
185,200193,000
52 wk Range
31,300257,500
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
298380 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
183,200
Downside
-1.40%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales growth in the current year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Sell
Moving Averages
Strong Sell
ABL Bio Company Profile
ABL Bio Inc., a biotech research company, focuses on the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases. The company offers ABL301, which is in the phase 1 clinical stage for the treatment of parkinson’s disease; ABL503 and ABL111 that is in phase 1 clinical stage for the treatment of solid tumor; and ABL102 for the treatment of solid and blood tumor. It also provides ABL103 for the treatment solid cancers; ABL104 for the treatment of solid tumor; and ABL105, which is in phase 1 clinical stage for the treatment of solid tumor. ABL Bio Inc. was incorporated in 2016 and is based in Seoul, South Korea.
Compare 298380 to Peers and Sector
Metrics to compare | 298380 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship298380PeersSector | |
|---|---|---|---|---|
P/E Ratio | −358.7x | −17.1x | −0.5x | |
PEG Ratio | −8.20 | −0.22 | 0.00 | |
Price/Book | 56.4x | 3.3x | 2.6x | |
Price / LTM Sales | 116.2x | 19.6x | 3.3x | |
Upside (Analyst Target) | 2.3% | 15.1% | 45.0% | |
Fair Value Upside | Unlock | 3.3% | 5.1% | Unlock |
Analyst Ratings
5 Buy
0 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 183,200
(-1.40% Downside)
Earnings
Latest Release
Nov 11, 2025
EPS / Forecast
-395.00 / -101.20
Revenue / Forecast
1.44B / --
People Also Watch
FAQ
What Is the ABL Bio (298380) Share Price Today?
The live ABL Bio share price today is 185,800
What Stock Exchange Does ABL Bio (298380) Trade On?
ABL Bio is listed and trades on the KOSDAQ.
What Is the Ticker (Stock Symbol) for ABL Bio?
The stock symbol (also called a 'ticker') for ABL Bio is "298380."
What Is the Current ABL Bio Market Cap?
As of today, ABL Bio market capitalisation is 10.27T.
What Is ABL Bio's (298380) Earnings Per Share (TTM)?
The ABL Bio EPS is currently -575.68 (Trailing Twelve Months).
Is 298380 a Buy or Sell From a Technical Analyst Perspective?
Based on today's ABL Bio moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has ABL Bio Stock Split?
ABL Bio has split 0 times. (See the 298380 stock split history page for full effective split date and price information.)
How Many Employees Does ABL Bio Have?
ABL Bio has 102 employees.
What is the current trading status of ABL Bio (298380)?
As of 10 Feb 2026, ABL Bio (298380) is trading at a price of 185,800, with a previous close of 189,200. The stock has fluctuated within a day range of 185,200 to 193,000, while its 52-week range spans from 31,300 to 257,500.
What Is ABL Bio (298380) Price Target According to Analysts?
The average 12-month price target for ABL Bio is KRW183,200, with a high estimate of KRW280000 and a low estimate of KRW86000. 5 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an -1.40% Downside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.